Unknown NA INTERVENTIONAL 3-arm NCT04527133

An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19

Sponsor: Aviron LLC

Conditions COVID-19

Interventions Aprotinin

Updated 6 times since 2020 Last updated: Aug 25, 2020 Started: Jun 11, 2020 Primary completion: Aug 11, 2020 Completion: Aug 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on COVID-19, this trial is ongoing. The trial is conducted by Aviron LLC and has accumulated 6 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown NA
Sep 2024 — Sep 2025 [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Nov 2022 — Jul 2024 [monthly]

Unknown Status NA

Status: Active Not Recruiting → Unknown Status
Jan 2021 — Nov 2022 [monthly]

Active Not Recruiting NA

▶ Show 1 earlier version

Sep 2020 — Jan 2021 [monthly]

Active Not Recruiting NA

First recorded

Jun 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Aviron LLC

Data source: Aviron LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Smolensk, Russia